266 related articles for article (PubMed ID: 26457375)
1. Systemic sclerosis: from pathogenesis to targeted therapy.
Denton CP
Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S3-7. PubMed ID: 26457375
[TBL] [Abstract][Full Text] [Related]
2. Innovative antifibrotic therapies in systemic sclerosis.
Beyer C; Distler O; Distler JH
Curr Opin Rheumatol; 2012 May; 24(3):274-80. PubMed ID: 22450392
[TBL] [Abstract][Full Text] [Related]
3. Clinical Trial Design Issues in Systemic Sclerosis: an Update.
Gordon JK; Domsic RT
Curr Rheumatol Rep; 2016 Jun; 18(6):38. PubMed ID: 27146381
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement.
De Luca G; Cavalli G; Campochiaro C; Bruni C; Tomelleri A; Dagna L; Matucci-Cerinic M
Front Immunol; 2021; 12():653950. PubMed ID: 33833766
[TBL] [Abstract][Full Text] [Related]
5. Targeting Costimulatory Pathways in Systemic Sclerosis.
Boleto G; Allanore Y; Avouac J
Front Immunol; 2018; 9():2998. PubMed ID: 30619351
[TBL] [Abstract][Full Text] [Related]
6. Future targets in the management of systemic sclerosis.
Tyndall A; Matucci-Cerinic M; Müller-Ladner U
Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii49-53. PubMed ID: 19487225
[TBL] [Abstract][Full Text] [Related]
7. Molecular and cellular pathways as treatment targets for biologic therapies in systemic sclerosis.
Dimitroulas T; Daoussis D; Garyfallos A; Sfikakis PP; Kitas GD
Curr Med Chem; 2015; 22(16):1943-55. PubMed ID: 25850767
[TBL] [Abstract][Full Text] [Related]
8. Systemic sclerosis: an update.
Varga J
Bull NYU Hosp Jt Dis; 2008; 66(3):198-202. PubMed ID: 18937632
[TBL] [Abstract][Full Text] [Related]
9. Systemic sclerosis and localized scleroderma--current concepts and novel targets for therapy.
Distler O; Cozzio A
Semin Immunopathol; 2016 Jan; 38(1):87-95. PubMed ID: 26577237
[TBL] [Abstract][Full Text] [Related]
10. New developments in the pathogenesis of systemic sclerosis.
Sakkas LI
Autoimmunity; 2005 Mar; 38(2):113-6. PubMed ID: 16040330
[TBL] [Abstract][Full Text] [Related]
11. Emerging cellular and molecular targets in fibrosis: implications for scleroderma pathogenesis and targeted therapy.
Castelino FV; Varga J
Curr Opin Rheumatol; 2014 Nov; 26(6):607-14. PubMed ID: 25191991
[TBL] [Abstract][Full Text] [Related]
12. Cytokines in the immunopathology of systemic sclerosis.
Raja J; Denton CP
Semin Immunopathol; 2015 Sep; 37(5):543-57. PubMed ID: 26152640
[TBL] [Abstract][Full Text] [Related]
13. Advances in pathogenesis and treatment of systemic sclerosis.
Denton CP
Clin Med (Lond); 2016 Feb; 16(1):55-60. PubMed ID: 26833515
[TBL] [Abstract][Full Text] [Related]
14. Targeting vascular disease in systemic sclerosis.
Kowal-Bielecka O
Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):401-7. PubMed ID: 17214586
[TBL] [Abstract][Full Text] [Related]
15. Targeting fibrosis in systemic sclerosis.
Lafyatis R
Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):395-400. PubMed ID: 17214585
[TBL] [Abstract][Full Text] [Related]
16. [Systemic sclerosis-clinical picture, diagnosis, and treatment].
Becker MO; Distler O; Maurer B
Z Rheumatol; 2019 Jun; 78(5):439-457. PubMed ID: 31089800
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic targets in systemic sclerosis.
Denton CP
Arthritis Res Ther; 2007; 9 Suppl 2(Suppl 2):S6. PubMed ID: 17767744
[TBL] [Abstract][Full Text] [Related]
18. An update on recent randomized clinical trials in systemic sclerosis.
Boleto G; Avouac J; Allanore Y
Joint Bone Spine; 2021 Oct; 88(5):105184. PubMed ID: 33887472
[TBL] [Abstract][Full Text] [Related]
19. Is immunosuppressive therapy the anchor treatment to achieve remission in systemic sclerosis?
Cappelli S; Bellando-Randone S; Guiducci S; Matucci-Cerinic M
Rheumatology (Oxford); 2014 Jun; 53(6):975-87. PubMed ID: 24185765
[TBL] [Abstract][Full Text] [Related]
20. Systemic sclerosis - a systematic overview: part 2 - immunosuppression, treatment of SSc-associated vasculopathy, and treatment of pulmonary arterial hypertension.
Opitz C; Klein-Weigel PF; Riemekasten G
Vasa; 2011 Jan; 40(1):20-30. PubMed ID: 21283970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
